Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial.
Blood. 2020 Jun 11;135(24):2137-2145. doi: 10.1182/blood.2020004856.
Blood. 2020.
PMID: 32219442
Free PMC article.
Clinical Trial.